Literature DB >> 16091244

CD4+ T-cell depletion in HIV infection: killed by friendly fire?

Abeer Moanna1, Richard Dunham, Mirko Paiardini, Guido Silvestri.   

Abstract

Recent studies have emphasized the role of a chronic, generalized activation of the immune system as a prominent cause of CD4+ T-cell depletion in HIV-infected patients. The HIV-induced immune activation is a strong predictor of disease progression in humans, and lack of immune activation is a key feature of nonpathogenic simian immunodeficiency virus (SIV) infection of natural hosts. The mechanisms by which immune activation induces CD4+ T-cell depletion are still incompletely understood, but likely involve changes in the complex dynamics of the naive, memory, and effector subsets of T cells. A better understanding of how HIV-induced immune activation leads to CD4+ T-cell depletion may provide new targets for immune-based interventions that could be used, in addition to standard antiretroviral therapy, to slow disease progression in HIV-infected individuals.

Entities:  

Mesh:

Year:  2005        PMID: 16091244     DOI: 10.1007/s11904-996-0004-3

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN: 1548-3568            Impact factor:   5.071


  70 in total

1.  Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy.

Authors:  H Mohri; A S Perelson; K Tung; R M Ribeiro; B Ramratnam; M Markowitz; R Kost; A Hurley; L Weinberger; D Cesar; M K Hellerstein; D D Ho
Journal:  J Exp Med       Date:  2001-11-05       Impact factor: 14.307

Review 2.  HIV-1 pathogenesis.

Authors:  Mario Stevenson
Journal:  Nat Med       Date:  2003-07       Impact factor: 53.440

Review 3.  Similarities and differences in CD4+ and CD8+ effector and memory T cell generation.

Authors:  Robert A Seder; Rafi Ahmed
Journal:  Nat Immunol       Date:  2003-09       Impact factor: 25.606

4.  Placebo-controlled trial of cyclosporin-A in HIV-1 disease: implications for solid organ transplantation.

Authors:  Leonard H Calabrese; Michael M Lederman; John Spritzler; Robert W Coombs; Lawrence Fox; Barbara Schock; Belinda Yen-Lieberman; Ronald Johnson; Donna Mildvan; Namita Parekh
Journal:  J Acquir Immune Defic Syndr       Date:  2002-04-01       Impact factor: 3.731

Review 5.  T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock.

Authors:  M D Hazenberg; D Hamann; H Schuitemaker; F Miedema
Journal:  Nat Immunol       Date:  2000-10       Impact factor: 25.606

6.  Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.

Authors:  R A Koup; J T Safrit; Y Cao; C A Andrews; G McLeod; W Borkowsky; C Farthing; D D Ho
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

7.  Programmed death of T cells in HIV-1 infection.

Authors:  L Meyaard; S A Otto; R R Jonker; M J Mijnster; R P Keet; F Miedema
Journal:  Science       Date:  1992-07-10       Impact factor: 47.728

8.  Highly active antiretroviral therapy during early HIV infection reverses T-cell activation and maturation abnormalities. Swiss HIV Cohort Study.

Authors:  L R Bisset; R W Cone; W Huber; M Battegay; P L Vernazza; R Weber; P J Grob; M Opravil
Journal:  AIDS       Date:  1998-11-12       Impact factor: 4.177

9.  Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315.

Authors:  M M Lederman; E Connick; A Landay; D R Kuritzkes; J Spritzler; M St Clair; B L Kotzin; L Fox; M H Chiozzi; J M Leonard; F Rousseau; M Wade; J D Roe; A Martinez; H Kessler
Journal:  J Infect Dis       Date:  1998-07       Impact factor: 5.226

10.  Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression.

Authors:  M L Gougeon; H Lecoeur; A Dulioust; M G Enouf; M Crouvoiser; C Goujard; T Debord; L Montagnier
Journal:  J Immunol       Date:  1996-05-01       Impact factor: 5.422

View more
  11 in total

1.  Viral dynamics model with CTL immune response incorporating antiretroviral therapy.

Authors:  Yan Wang; Yicang Zhou; Fred Brauer; Jane M Heffernan
Journal:  J Math Biol       Date:  2012-08-29       Impact factor: 2.259

2.  Soluble Fas and Fas ligand in HIV/HCV coinfected patients and impact of HCV therapy.

Authors:  M Guzmán-Fulgencio; J Berenguer; M García-Álvarez; D Micheloud; J C López; J Cosín; I Fernández de Castro; P Catalán; P Miralles; S Resino
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-03-26       Impact factor: 3.267

Review 3.  Dissecting the role of dendritic cells in simian immunodeficiency virus infection and AIDS.

Authors:  Elizabeth R Wonderlich; Muhamuda Kader; Viskam Wijewardana; Simon M Barratt-Boyes
Journal:  Immunol Res       Date:  2011-08       Impact factor: 2.829

Review 4.  Chronic innate immune activation as a cause of HIV-1 immunopathogenesis.

Authors:  Adriano Boasso; Gene M Shearer
Journal:  Clin Immunol       Date:  2007-10-03       Impact factor: 3.969

5.  Engagement of the CD4 receptor affects the redistribution of Lck to the immunological synapse in primary T cells: implications for T-cell activation during human immunodeficiency virus type 1 infection.

Authors:  Alice M Nyakeriga; Carl J Fichtenbaum; Jens Goebel; Stella A Nicolaou; Laura Conforti; Claire A Chougnet
Journal:  J Virol       Date:  2008-11-19       Impact factor: 5.103

6.  Relationships between IL-17(+) subsets, Tregs and pDCs that distinguish among SIV infected elite controllers, low, medium and high viral load rhesus macaques.

Authors:  Ladawan Khowawisetsut; Kovit Pattanapanyasat; Nattawat Onlamoon; Ann E Mayne; Dawn M Little; Francois Villinger; Aftab A Ansari
Journal:  PLoS One       Date:  2013-04-19       Impact factor: 3.240

7.  Nef-specific CD45RA+ CD8+ T cells secreting MIP-1beta but not IFN-gamma are associated with nonprogressive HIV-1 infection.

Authors:  Mauro Malnati; Antonio Cosma; Claudia J Dembek; Sarah Kutscher; Silvia Heltai; Simone Allgayer; Priscilla Biswas; Silvia Ghezzi; Elisa Vicenzi; Dieter Hoffmann; Peter Reitmeir; Giuseppe Tambussi; Johannes R Bogner; Paolo Lusso; Hans-J Stellbrink; Elena Santagostino; Thomas Vollbrecht; Frank D Goebel; Ulrike Protzer; Rika Draenert; Marco Tinelli; Guido Poli; Volker Erfle
Journal:  AIDS Res Ther       Date:  2010-07-02       Impact factor: 2.250

8.  The investigation of CD4+T-cell functions in primary HIV infection with antiretroviral therapy.

Authors:  Yu Sun; Yajing Fu; Zining Zhang; Tian Tang; Jing Liu; Haibo Ding; Xiaoxu Han; Junjie Xu; Zhenxing Chu; Hong Shang; Yongjun Jiang
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

9.  HIV-induced type I interferon and tryptophan catabolism drive T cell dysfunction despite phenotypic activation.

Authors:  Adriano Boasso; Andrew W Hardy; Stephanie A Anderson; Matthew J Dolan; Gene M Shearer
Journal:  PLoS One       Date:  2008-08-13       Impact factor: 3.240

Review 10.  The enduring tale of T cells in HIV immunopathogenesis.

Authors:  Madhu Vajpayee; Neema Negi; Sravya Kurapati
Journal:  Indian J Med Res       Date:  2013-11       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.